SMPD2 Antilichaam - N-terminalgebied: FITC (ARP45417 T100-FITC)

Sphingomyelin phosphodiesterase 2, neutral membrane (neutral sphingomyelinase)

ISC1, NSMASE, NSMASE1

6610

O60906

NP_003071

Human, Mouse, Rat, Cow, Dog, Guinea Pig, Horse, Rabbit

The immunogen is a synthetic peptide directed towards the N terminal region of human SMPD2

SMPD2 converts sphingomyelin to ceramide. Hydrolyze 1-acyl-2-lyso-sn-glycero-3-phosphocholine (lyso-PC) and 1-O-alkyl-2-lyso-sn-glycero-3-phosphocholine (lyso-platelet-activating factor) . The physiological substrate seems to be Lyso-PAF.

UBC; PIK3CG

FITC: Fluorescein Isothiocyanate

Polyclonal Antibody

WB

0.5 mg/ml

Cow: 79%; Dog: 86%; Guinea Pig: 79%; Horse: 86%; Human: 100%; Mouse: 77%; Rabbit: 79%; Rat: 79%

Liquid. Purified antibody supplied in 1x PBS buffer.

All conjugated antibodies should be stored in light-protected vials or covered with a light protecting material (i.e. aluminum foil) . Conjugated antibodies are stable for at least 12 months at 4C. If longer storage is desired (24 months), conjugates may be diluted with up to 50% glycerol and stored at -20C to -80C. Freezing and thawing conjugated antibodies will compromise enzyme activity as well as antibody binding.

48kDa

Kimura, K., (2006) Genome Res. 16 (1), 55-65

Wet Ice

423

SMPD2

SMPD2

Rabbit

Sphingomyelin phosphodiesterase 2

NM_003080

RQKLSPTYPAAHHFRSGIIGSGLCVFSKHPIQELTQHIYTLNGYPYMIHH